Software & Services
Betfred.com has extended its partnership with digital marketing platform provider OtherLevels (ASX:OLV) to take on the supplier's complete portfolio of player engagement messaging services.
Australian Securities Exchange and Frankfurt Stock Exchange cross listed iSignthis Ltd (ASX:ISX) (FRA:TA8), the world leading RegTech for identity verification and payment services, is pleased to announce that it has contracted further merchants to ISXPay Australia.
Family Zone Cyber Safety (ASX:FZO) has signed a share sale agreement to acquire 100% of Linewize Services Limited and Linewize Limited, which together comprise a leading New Zealand-based provider of cyber security and safety services. Highlights of the transaction include the following.
Further to the announcement dated 9 October 2017, the Board of TopBetta Holdings Limited (ASX:TBH) is pleased to announce that it has completed the acquisition of the code base of the Global Tote product from Modern Wagering Systems Pty Ltd on the terms set out in the Announcement.
iSignthis Ltd (ASX:ISX) (FRA:TA8), the world leading RegTech for identity verification and payment services, is pleased to announce that it has contracted and commenced the integration of its services with Dialinvest International N.V.
iSignthis Ltd (ASX:ISX) provides the Company's latest Investor Presentation.
The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that it has entered into a Binding Share Sale and Purchase Agreement to divest its equity interests in early stage mobile technology development company Digital4ge Pty Ltd and social media-driven product placement platform Visual Amplifiers Ltd.
Australian Securities and Frankfurt Stock Exchange cross listed iSignthis Ltd (ASX:ISX) (FRA:TA8), the global leader in RegTech for identity verification, is pleased to announce that it has executed an agreement to integrate its Paydentity(TM) UBO Service with Web Shield Ltd's InvestiGate platform.
OtherLevels Holdings Limited (ASX:OLV) has announced that it has signed a leading wagering operator with licenced operations in the United Kingdom and Australia.
Australian Securities and Frankfurt Stock Exchange cross listed iSignthis Ltd (ASX:ISX) (FRA:TA8), the global leader in RegTech for identity verification and transactional banking/payments, is pleased to provide the following business update and Appendix 4C for the quarter ended 30th September 2017.
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Managing Director and CEO Commencement Date
- Deep Yellow Limited (ASX:DYL) Exploration Update
- Central Petroleum Limited (ASX:CTP) Appoints Mr Joel Riddle as Director
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Canadian Patent Secured for PromarkerEso Test for Esophageal Adenocarcinoma
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of CEO and Managing Director
- BPH Energy Limited (ASX:BPH) Raises $1.2M to Accelerate Funding of Hydrocarbon and Cortical Investments
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published






























